CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS);POXEL;INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);ENS - ECOLE NORMALE SUPERIEURE DE LYON;UNIVERSITE CLAUDE BERNARD-LYON 1;EDE
发明人:
ANDRE, PATRICE,LOTTEAU, VINCENT,RADREAU, PAULINE,GILARDONE, MARINE,PATIN, AMAURY,ROCHE, DIDIER,CRAVO, DANIEL,HALLAKOU-BOZEC, SOPHIE
申请号：
CA2923090
公开号：
CA2923090A1
申请日:
2014.09.10
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The present invention relates to methods and pharmaceutical compositions for the treatment of hepatitis B virus infection. In particular, the present invention relates to farnesoid X receptor (FXR) agonists for use in a method for the treatment of hepatitis B virus infection in a subject in need thereof.
